Virax Biolabs Group Limited - VRAX
About Gravity Analytica
Recent News
- 08.28.2025 - Virax Biolabs COO, Dr Nigel McCracken, Discusses Immune Decoding with ViraxImmuneTM on the MedTech Gurus Podcast
- 08.26.2025 - Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early SeptemberV
- 08.26.2025 - Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September
- 08.08.2025 - Major New Study Reveals Immunological Insights Into ME/CFS, Further Supporting Blood-based Diagnostic Testing and Research
- 07.30.2025 - ELISA vs ELISpot: Select The Right Assay For Your Research
- 07.29.2025 - Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy.
- 07.29.2025 - Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy
- 07.18.2025 - Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
- 07.02.2025 - Diagnosing Long COVID: A Gut-Immune Perspective.
- 05.12.2025 - Chronic Illness and The Immune System: Chronic Illness and The Immune System: Could ViraxImmune™ Offer a Critical Diagnostic Breakthrough?